INTRODUCTION
============

Mercury (Hg) exists naturally as elemental Hg, in inorganic mercurous and mercuric compounds, and in organic Hg compounds. These 3 types of Hg are known to have different toxicity and health effects \[[@b1-jpmph-50-6-377],[@b2-jpmph-50-6-377]\]. Elemental and inorganic forms of Hg are predominantly absorbed through the respiratory tract, while organic Hg is mainly absorbed and bioaccumulated through the gastrointestinal tract because of its highly lipophilic nature \[[@b1-jpmph-50-6-377]\]. Hg is removed from the human body through urine or feces, and the half-life of total Hg in the blood was found to be 57 days on average in a Japanese study \[[@b3-jpmph-50-6-377]\].

In the 2011-2012 National Health and Nutrition Examination Survey (NHANES) data, the geometric mean (95% confidence interval \[CI\]) of blood Hg concentrations in Asians was 1.93 μg/L (1.65 to 2.27 μg/L), which was the highest of all the races \[[@b4-jpmph-50-6-377]\]. In the same study, levels of 2.58 μg/L were found in Chinese participants, 1.29 μg/L in Indians, and 2.48 μg/L in other Asian subgroups \[[@b4-jpmph-50-6-377]\]. However, the geometric mean (95% CI) of blood Hg concentrations in the 2012 and 2015 Korean National Environmental Health Survey (KoNEHS) were 3.08 μg/L (2.96 to 3.21 μg/L) and 3.11 μg/L (3.02 to 3.21 μg/L), respectively, which were higher than the NHANES findings for Asians in 2011-2012. In the 2011 Korea National Health and Nutrition Examination Survey (KNHANES), the corresponding level was 3.08 μg/L (2.95 to 3.22 μg/L), which was lower than that of the KoNEHS in 2015, but also higher than the level of the Asians analyzed in the NHANES \[[@b5-jpmph-50-6-377]\].

The toxicity of high-level Hg exposure is well known from Minamata disease in Japan, outbreaks of which occurred in 1956 and 1965 due to the consumption of Hg-contaminated seafood \[[@b6-jpmph-50-6-377]\]. In addition to neurological toxicity, high levels of Hg exposure affect various human organs, including the cardiovascular, endocrine, reproductive, and immune systems \[[@b7-jpmph-50-6-377]\]. The mechanisms of its toxicity have been suggested to involve degeneration, oxidative stress, and changes in the energy metabolism of the cell, but are not fully understood \[[@b8-jpmph-50-6-377]\]. The liver plays a major role in metabolism and detoxification, and Hg is thought to have structural and functional effects on the liver, but studies of the effects of Hg exposure on human liver tissue, particularly at relatively low levels, are limited.

Previous epidemiological studies of the effects of Hg exposure on human liver function have shown inconsistent results. A previous epidemiological study showed that the Minamata area, despite being contaminated with methylmercury, did not have a higher prevalence of liver disease than other areas \[[@b9-jpmph-50-6-377]\]. In a study of 320 adolescents, no significant associations were found between blood Hg levels and aspartate aminotransferase (AST) or alanine transaminase (ALT) levels \[[@b10-jpmph-50-6-377]\]. Other epidemiological studies in adults and the elderly showed a significant positive association between Hg and AST, ALT, and gamma-glutamyltransferase (GGT) \[[@b11-jpmph-50-6-377]-[@b14-jpmph-50-6-377]\].

Previous epidemiological studies have mostly analyzed cross-sectional data \[[@b10-jpmph-50-6-377]-[@b12-jpmph-50-6-377],[@b14-jpmph-50-6-377]\] and did not consider fish consumption as a potential confounder, although fish are a major source of Hg exposure \[[@b10-jpmph-50-6-377],[@b11-jpmph-50-6-377],[@b13-jpmph-50-6-377],[@b14-jpmph-50-6-377]\]. In addition, no studies have examined the possibility of a nonlinear relationship between blood Hg and liver function indices, or the possible role of gender. Therefore, this study aimed to examine associations between total blood Hg concentration and levels of AST, ALT, and GGT, known risk factors for reduced liver function and non-alcoholic fatty liver disease, with stratification by gender.

METHODS
=======

Study Population
----------------

The study participants were a subgroup of 2118 adults aged ≥19 years from the Korean Research Project on the Integrated Exposure Assessment of Hazardous Substances for Food Safety cohort recruited nationwide from June 3, 2010 to July 28, 2011. Subjects were sampled by a probability method based on household units stratified by 15 metropolises and provinces (Seoul, Gwangju, Busan, Incheon, Daegu, Daejeon, Ulsan, Gyeonggi, Gangwon, Chungbuk, Chungnam, Jeonbuk, Jeonnam, Gyeongbuk, and Gyeongnam), gender, age, and the sample size was allocated by the square root method \[[@b15-jpmph-50-6-377]\].

Of the 2118 participants ≥19 years old in the baseline survey, 514 were followed up from October 2, 2014 to September 12, 2015. The follow-up was carried out in 3 sequential steps: mailing a notice, sending a mobile phone text message with a request to participate, and making a telephone call to ask subjects to participate after a certain time interval. We obtained informed consent and conducted examinations at community centers or house visits. The follow-up involved administration of a questionnaire, a physical examination, 24-hour diet recall, and blood tests, the same items as in the baseline survey.

Of the 514 followed-up participants, after excluding 6 subjects whose blood Hg levels or liver function indices (AST, ALT, GGT) were not measured in the baseline or follow-up, 508 participants were included in the analysis ([Supplemental Figure 1](#SD1){ref-type="supplementary-material"}).

This study was conducted in accordance with the Declaration of Helsinki of the World Medical Association (<http://www.wma.net>) and approved by the institutional review board of Dankook University Hospital (DKUH 2010-04-0093, DKUH 2011-03-0086, DKUH 2014-02-016, DKUH 2015-01-006).

Blood Mercury
-------------

To analyze blood Hg levels, 3 mL of blood was collected in an ethylenediaminetetraacetic acid tube as part of the 2010-2011 baseline survey and the 2014-2015 follow-up survey. Whole blood was stored at -80°C until analysis. The blood Hg analysis was performed using a MA-3000 direct Hg analyzer (Nippon Instrument Co., Tokyo, Japan). Quality control of the blood Hg analysis was performed intermittently using standard reference materials from the German external quality assessment scheme (Germany) and Bio-Rad (Bio-Rad Inc., Hercules, California, USA). The limit of detection was 0.20 μg/L, and no samples had a Hg level below the limit of detection.

Liver Function Enzymes
----------------------

To analyze serum AST, ALT and GGT levels, 8 mL of blood was collected in an serum separator tube. The collected blood was stored at -80°C until analysis. The liver enzymes were analyzed using a Hitachi 7600 DDP analyzer (Hitachi High-Technologies, Tokyo, Japan).

Covariates
----------

Fish intake was measured by the 24-hour diet recall method in the baseline survey and at follow-up. The 24-hour diet recall was designed to record the diet of 2 non-consecutive days, and the average intake (g/kg/d) was calculated for various food groups. Intake was classified into the first (\<0.20 g/kg/d), second (0.20-0.72 g/kg/d), third (0.73-1.45 g/kg/d), and fourth quarters (≥1.46 g/kg/d) of total fish consumption. In addition, data from the questionnaire regarding gender, age (years), residence (urban or rural area), income (\<100, 100-200, 200-300, 300-400, 400-600, or ≥600×10^4^ Korean won/mo), lifetime smoking (yes or no), frequency of alcohol consumption (none, less than once a month, about once a month, 2-4 times a month, 2-3 times a week, or ≥4 times a week), and past medical history (yes or no) of hypertension (HTN), diabetes mellitus (DM), kidney disease, tuberculosis (TB), dyslipidemia, or hepatitis B were included as covariates. For the residence variable, we divided regions into 2 groups: urban (Seoul, Ulsan, Incheon, Daejeon, Gwangju, Daegu, and Busan) and rural (all others).

Statistical Analysis
--------------------

The distribution of general characteristics, blood Hg levels, and liver enzyme levels was assessed by descriptive statistics such as frequency, proportion, arithmetic/geometric mean and standard deviation (SD), minimum, 25th percentile, median, 75th percentile, and maximum. Because the distributions of blood Hg and liver enzyme levels were right-skewed, log-transformed values were used to test the differences according to the subjects' characteristics, and the Student *t*-test and analysis of variance were used.

A generalized linear model (GLM) was used to analyze cross-sectional associations between blood Hg and liver enzyme levels at baseline and follow-up. Nonlinear relationships were examined using a generalized additive mixed model (GAMM). In this model, the base-2 log blood Hg level was given a cubic regression spline function. The population-averaged association over the period of the study between blood Hg and liver enzyme levels was analyzed using a generalized estimating equations (GEE) model considering repeated measures for the same individuals stratified by gender. In the GEE analysis, the interaction of blood Hg and the frequency of alcohol consumption in association with liver enzymes was evaluated.

In all analyses, natural log-transformed liver enzyme levels and base 2 log-transformed blood Hg levels were used as response and predictor variables, respectively. Survey wave, gender, age, income, fish consumption, smoking, frequency of alcohol consumption, and past medical history were considered as covariates in the regression models, and individuals were included in GAMM as random intercepts. Each variable corresponded to values measured at each survey wave in the GLM, and were considered to be time-varying covariates in the GAMM and GEE. The significance level for tests was 0.05, and R version 3.3.3 (Comprehensive R Archive Network: <http://cran.r-project.org>) was used.

RESULTS
=======

In the baseline survey, the geometric mean (geometric SD) levels of blood Hg, ALT, AST, and GGT in all participants were 4.33 μg/L (1.94 μg/L), 21.2 IU/L (1.4 IU/L), 18.3 IU/L (1.7 IU/L), and 23.4 IU/L (2.0 IU/L), respectively. Blood Hg levels were significantly higher in men than women, as age increased, in smokers than non-smokers, as fish intake increased, as the frequency of alcohol consumption increased, and in individuals with a history of HTN or TB. All 3 liver enzymes were significantly higher in men than women, as age increased, in smokers than non-smokers, as the frequency of alcohol consumption increased, and in those with a history of HTN. ALT and GGT were significantly higher in those with a history of DM, ALT was significantly higher in those with a history of TB, and AST and ALT were significantly higher in those with a history of hepatitis B than their respective counterparts ([Table 1](#t1-jpmph-50-6-377){ref-type="table"}).

Compared to the baseline values, the follow-up concentrations of blood Hg and AST decreased, that of ALT increased, and that of GGT was similar (*p*\<0.001, *p*\<0.001, *p*\<0.001, and *p*=0.38, respectively) ([Table 2](#t2-jpmph-50-6-377){ref-type="table"}). Descriptive findings regarding the distribution of the change in levels of each enzyme, as well as Hg concentrations, from the baseline to follow-up are shown in [Supplemental Table 1](#SD2){ref-type="supplementary-material"}.

Significant positive associations were found between blood Hg and GGT at baseline and follow-up (in all participants and in women), but no significant associations with AST or ALT were observed. Although the association of blood Hg with AST and ALT in all participants showed a significant difference between the 2 survey waves, there was no significant difference after stratification by gender ([Table 3](#t3-jpmph-50-6-377){ref-type="table"}). There was no statistically significant association between blood Hg levels at baseline or changes in blood Hg and changes in liver enzyme levels between surveys ([Supplemental Table 2](#SD3){ref-type="supplementary-material"}).

The relationships between blood Hg levels and liver enzyme levels are illustrated in [Figure 1](#f1-jpmph-50-6-377){ref-type="fig"}. In men, AST and ALT showed little change as blood Hg levels increased, and GGT showed an increase with a downward curvature. In women, AST, ALT, and GGT showed an increase with an upward curvature.

The associations between blood Hg and AST or ALT, when adjusted for other covariates and individual correlations in repeated measurements, were not significant in either gender ([Table 4](#t4-jpmph-50-6-377){ref-type="table"}). GGT showed a significant association with blood Hg levels in women and borderline significance in men. The association between blood Hg and AST was significantly different by gender (*p* for interaction=0.02).

In women who consumed alcohol ≥2-3 times per week, all 3 liver enzymes showed significant positive associations with blood Hg levels, and the effects of blood Hg and frequency of alcohol consumption on GGT showed a significant synergistic interaction (*p* for interaction=0.008) ([Table 4](#t4-jpmph-50-6-377){ref-type="table"}). The frequency and amount of alcohol consumption were strongly correlated ([Supplemental Table 3](#SD4){ref-type="supplementary-material"}), and the results were similar to those of drinking frequency when the analysis was repeated using the amount of alcohol consumed ([Supplemental Table 4](#SD5){ref-type="supplementary-material"}).

DISCUSSION
==========

In this study, higher blood Hg levels were associated with higher serum GGT levels in men and women. Especially in women who drank alcohol frequently, higher blood Hg levels were significantly associated with elevated AST and ALT levels, as well as GGT, and a significant synergistic effect between Hg and alcohol consumption on liver enzyme levels was observed.

The geometric mean values of the blood Hg at baseline and follow-up were 4.33 μg/L and 3.18 μg/L, respectively. In the 2012 and 2015 KoNEHS data, the geometric mean levels of blood Hg were reported as 3.08 μg/L and 3.11 μg/L, respectively, and Seo et al. \[[@b5-jpmph-50-6-377]\] and Lee et al. \[[@b12-jpmph-50-6-377]\] reported values of 3.08 μg/L and 3.99 μg/L, respectively. Compared to those previous Korean studies, the baseline concentration in the present study was higher and the concentration at follow-up was similar.

In previous epidemiological studies, blood Hg showed a significant positive association with ALT in NHANES 2003-2004 \[[@b11-jpmph-50-6-377]\], and with AST and ALT in KNHANES 2008-2012 \[[@b12-jpmph-50-6-377]\]. A recent study \[[@b13-jpmph-50-6-377]\] reported significantly higher AST levels in the highest quarter of blood Hg levels than in the lowest quarter, and the odds of high ALT levels (\>35 IU/L) were 3.10 times higher in the highest quarter of blood Hg levels than in the lowest quarter in a repeated-measures study of Koreans over 60 years old. However, other studies have reported no association \[[@b9-jpmph-50-6-377],[@b10-jpmph-50-6-377]\], and conflicting results have been reported depending on whether liver dysfunction was defined as a continuous or dichotomous variable within the same study \[[@b13-jpmph-50-6-377]\]. Significantly higher GGT levels were found in the second-highest and highest quarters of blood Hg levels than in the lowest quarter \[[@b13-jpmph-50-6-377]\], and the odds of high GGT (\>47 IU/L for men and \>21 IU/L for women) were 2.59 times higher for men and 2.03 times higher for women in the highest quarter of blood Hg levels than in the lowest quarter \[[@b14-jpmph-50-6-377]\]. The differences in results among studies may be explained by various factors, such as differences in the adjusted confounding variables, study design, sample size, and whether effect modifiers such as alcohol consumption and gender were considered. In the present study, an interaction between blood Hg levels and alcohol consumption was observed for GGT in women, which was consistent with previous results. This may have been because GGT is a more sensitive biomarker for alcohol consumption than AST or ALT \[[@b13-jpmph-50-6-377]\].

The biological mechanism of associations between Hg exposure and liver dysfunction is mainly explained by oxidative stress, cell death, and impairment of metabolism. In a study using NHANES 1988-1994 data, negative associations of GGT with antioxidants including a-carotene, h-carotene, h-cryptoxanthin, zeaxanthin/lutein, lycopene, and vitamin C were reported, suggesting that GGT may be considered an early oxidative stress marker \[[@b16-jpmph-50-6-377]\]. In an animal study of male rats exposed to Hg, AST, ALT, and GGT were significantly elevated, and marked damage or necrotic changes were observed in most of the liver tissue samples upon a histological examination \[[@b17-jpmph-50-6-377]\]. Degenerative changes and large lysed areas in liver parenchyma in Hg-exposed zebrafish have been observed \[[@b18-jpmph-50-6-377]\]. In addition, Hg exposure in zebrafish induced deregulation of oxidative stress, intrinsic apoptotic pathways, and nuclear receptor and kinase activity \[[@b19-jpmph-50-6-377]\], suggesting that gluconeogenesis and adipogenesis occur in these processes and that hepatotoxicity occurs through cell death, mitochondrial dysfunction, endocrine disruption, and metabolic disorders. Koenig and Seneff \[[@b20-jpmph-50-6-377]\] proposed that GGT, an indicator of alcohol-related liver disease, is an important biomarker of cellular antioxidant inadequacy. Therefore, the results of the present study that GGT was susceptible to elevated blood Hg levels, mediated through an interaction with alcohol consumption, imply that Hg may induce hepatotoxicity through oxidative stress.

The present study has several strengths. First, we considered fish consumption as a potential confounder when examining associations between blood Hg levels and liver function. Fish is a major source of Hg, and 80-90% of the organic Hg in the human body comes from fish and shellfish intake \[[@b21-jpmph-50-6-377]\]. Because methylmercury is highly lipophilic and bioaccumulative, methylmercury exposure occurs mostly via food intake, such as fish consumption. Fish consumption increases total blood Hg, while the antioxidant effects of fish oil and nutrients may offset the harmful effect of Hg on liver enzymes. Most previous studies have not considered fish consumption \[[@b13-jpmph-50-6-377],[@b14-jpmph-50-6-377]\]. Second, we examined the possibility of a nonlinear association between Hg levels and liver enzyme levels. Most previous epidemiological studies have examined linear relationships or Hg levels divided into quantiles, which could lead to biased results if these variables have a nonlinear relationship. In the present study, we did not find evidence of a nonlinear association between Hg levels and liver function, although further studies are warranted to replicate our findings. Third, we analyzed the data with consideration of the repeatedly measured and longitudinal structure of the data, whereas most previous studies on the associations between Hg and liver enzymes were purely cross-sectional.

Nonetheless, this study has some limitations. First, we did not have information on organic Hg per se; instead, we measured the total Hg concentration. However, it is known that organic Hg accounts for most of the Hg content in the human body \[[@b21-jpmph-50-6-377]\]. Specifically, methylmercury is known to contribute to about 90% of the total blood Hg concentration when the total Hg level is about 4 μg/L or more, and the total Hg in the general population is known to reflect organic Hg exposure unless individuals are exposed to high concentrations of inorganic Hg \[[@b22-jpmph-50-6-377]\]. Therefore, in the present study, the analysis of total blood Hg could also be interpreted meaningfully as an analysis of organic Hg to some extent. Second, fish consumption was measured by the 24-hour diet recall method. This method was based on 2 non-consecutive days of diet recall, and the average intake (g/kg/d) was calculated; this method may have introduced uncertainty in measurements of fish intake. Third, the frequency of alcohol consumption for the past year was measured by the questionnaire, whereas information on alcohol consumption the day before the test was not obtained, although this could have affected liver enzyme levels. However, because the introductory brochure provided to the enrollees contained information on drinking restrictions before the test, this impact should have been minimal.

In conclusion, total blood Hg exposure was associated with an increase in liver enzymes, particularly in women heavy drinkers. Women may be more sensitive to the hepatotoxic effects of Hg, and Hg exposure showed a synergistic effect on liver damage with a high frequency of alcohol consumption.
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###### 

Flow chart of the study population

###### 

Changes of blood mercury and liver enzymes from baseline (2010-2011) to follow-up (2014-2015)

###### 

Association between blood mercury and change of liver enzymes from baseline (2010-2011) to follow-up (2014-2015)

###### 

Association between frequency and amount of alcohol consumption

###### 

Generalized Estimating Equations (GEE) model on association between blood mercury levels and liver enzymes from baseline (2010-2011) to follow-up (2014-2015) stratified by gender

![Relationship between blood levels of Hg and liver enzymes in adults. The smoothing line is fitted by using the generalized additive model (GAM), and the gray shade is the 95% confidence bands for smooths. GAM used both baseline and follow-up data, and nonlinear relationship was evaluated using cubic regression spline function to base-2 log Hg, adjusted for gender (in all), age, income, fish consumption, smoking, drinking alcohol, past medical history of hypertension, diabetes mellitus, tuberculosis, hepatitis B, and survey wave with a random intercept for individuals. In each model, age, income, survey wave, fish consumption, smoking and drinking alcohol frequency as well as blood Hg and liver enzymes are considered as time-varying covariates. Hg, mercury; AST, aspartate aminotransferases; ALT, alanine transaminase; GGT, gamma-glutamyltransferase.](jpmph-50-6-377f1){#f1-jpmph-50-6-377}

###### 

Distribution of levels of blood Hg and liver enzymes according to the characteristics of study participants at baseline (2010-2011)

                                     n (%)         Hg (μg/L)     *p*-value^[1](#tfn1-jpmph-50-6-377){ref-type="table-fn"}^   AST (IU/L)   *p*-value^[1](#tfn1-jpmph-50-6-377){ref-type="table-fn"}^   ALT (IU/L)   *p*-value^[1](#tfn1-jpmph-50-6-377){ref-type="table-fn"}^   GGT (IU/L)   *p*-value^[1](#tfn1-jpmph-50-6-377){ref-type="table-fn"}^
  ---------------------------------- ------------- ------------- ----------------------------------------------------------- ------------ ----------------------------------------------------------- ------------ ----------------------------------------------------------- ------------ -----------------------------------------------------------
  Total                              508 (100.0)   4.33 (1.94)                                                               21.2 (1.4)                                                               18.3 (1.7)                                                               23.4 (2.0)   
  Gender                                                                                                                                                                                                                                                                                    
   Men                               211 (41.5)    5.71 (1.94)                                                               23.2 (1.4)                                                               22.6 (1.6)                                                               36.1 (2.0)   
   Women                             297 (58.5)    3.55 (1.80)   \<0.001                                                     19.8 (1.4)   \<0.001                                                     15.7 (1.6)   \<0.001                                                     17.2 (1.7)   \<0.001
  Age at baseline (y)                                                                                                                                                                                                                                                                       
   ≤29                               53 (10.4)     2.87 (1.70)                                                               19.2 (1.5)                                                               15.1 (2.1)                                                               17.5 (1.7)   
   30-39                             73 (14.4)     3.99 (1.77)                                                               18.3 (1.3)                                                               16.5 (1.6)                                                               20.4 (1.9)   
   40-49                             113 (22.2)    4.57 (2.06)                                                               21.3 (1.5)                                                               19.3 (1.7)                                                               26.0 (2.2)   
   50-59                             135 (26.6)    4.22 (1.86)                                                               21.8 (1.4)                                                               18.9 (1.6)                                                               22.3 (1.9)   
   ≥60                               134 (26.4)    5.20 (1.95)   \<0.001                                                     23.1 (1.3)   \<0.001                                                     19.3 (1.5)   0.008                                                       27.1 (2.0)   \<0.001
  Residence                                                                                                                                                                                                                                                                                 
   Rural area                        305 (60.0)    4.49 (1.89)                                                               21.0 (1.4)                                                               18.5 (1.7)                                                               24.1 (2.1)   
   Urban area                        203 (40.0)    4.09 (2.01)   0.12                                                        21.4 (1.4)   0.57                                                        18.1 (1.7)   0.64                                                        22.4 (1.9)   0.24
  Income (104 KRW/mo)                                                                                                                                                                                                                                                                       
   \<100                             83 (17.1)     4.34 (2.04)                                                               22.0 (1.4)                                                               18.3 (1.5)                                                               25.5 (2.0)   
   100-200                           112 (23.0)    4.48 (1.96)                                                               22.2 (1.4)                                                               19.3 (1.8)                                                               25.5 (2.2)   
   200-300                           140 (28.8)    4.32 (1.82)                                                               21.3 (1.5)                                                               17.9 (1.7)                                                               22.0 (2.1)   
   300-400                           77 (15.8)     4.42 (1.99)                                                               20.6 (1.3)                                                               18.5 (1.6)                                                               24.4 (1.8)   
   400-600                           55 (11.3)     3.84 (1.94)                                                               19.1 (1.3)                                                               17.0 (1.7)                                                               19.8 (1.8)   
   ≥600                              19 (3.9)      6.06 (2.10)   0.23                                                        20.4 (1.5)   0.14                                                        20.7 (1.9)   0.60                                                        24.4 (2.1)   0.19
  History of smoking                                                                                                                                                                                                                                                                        
   No                                332 (65.9)    3.74 (1.83)                                                               20.4 (1.4)                                                               16.5 (1.6)                                                               18.6 (1.7)   
   Yes                               172 (34.1)    5.76 (1.96)   \<0.001                                                     22.8 (1.5)   \<0.001                                                     22.3 (1.6)   \<0.001                                                     36.2 (2.1)   \<0.001
  Frequency of alcohol consumption                                                                                                                                                                                                                                                          
   None                              124 (24.6)    3.90 (1.95)                                                               20.9 (1.4)                                                               17.9 (1.6)                                                               19.6 (1.7)   
   \<1/mo                            74 (14.7)     3.61 (1.90)                                                               19.7 (1.4)                                                               16.1 (1.6)                                                               17.6 (1.7)   
   1/mo                              68 (13.5)     4.41 (1.74)                                                               20.2 (1.4)                                                               18.0 (1.7)                                                               19.9 (1.9)   
   2-4 times/mo                      117 (23.2)    3.97 (1.94)                                                               19.7 (1.3)                                                               17.1 (1.6)                                                               21.6 (1.8)   
   2-3 times/wk                      74 (14.7)     5.29 (1.86)                                                               23.5 (1.5)                                                               21.0 (1.8)                                                               32.8 (2.0)   
   4+ times/wk                       48 (9.5)      6.75 (1.89)   \<0.001                                                     26.2 (1.5)   \<0.001                                                     23.0 (1.6)   \<0.001                                                     51.9 (2.5)   \<0.001
  Fish consumption (g/kg/d)                                                                                                                                                                                                                                                                 
   1st quarter (\<0.20)              117 (23.1)    3.93 (1.91)                                                               22.0 (1.4)                                                               19.7 (1.7)                                                               27.9 (2.1)   
   2nd quarter (0.20-0.72)           139 (27.4)    3.90 (1.95)                                                               20.9 (1.5)                                                               17.5 (1.7)                                                               22.4 (2.0)   
   3rd quarter (0.73-1.45)           124 (24.5)    4.14 (1.95)                                                               20.8 (1.4)                                                               17.5 (1.7)                                                               20.7 (1.9)   
   4th quarter (≥1.46)               127 (25.0)    5.55 (1.83)   \<0.001                                                     21.1 (1.3)   0.61                                                        18.9 (1.6)   0.18                                                        23.8 (2.0)   0.007
  Past medical history                                                                                                                                                                                                                                                                      
   Hypertension                                                                                                                                                                                                                                                                             
    No                               362 (73.6)    4.07 (1.91)                                                               20.5 (1.4)                                                               17.4 (1.7)                                                               21.3 (1.9)   
    Yes                              130 (26.4)    5.13 (2.00)   0.001                                                       22.7 (1.4)   0.003                                                       20.7 (1.6)   0.001                                                       29.4 (2.1)   \<0.001
   Diabetes mellitus                                                                                                                                                                                                                                                                        
    No                               433 (88.5)    4.34 (1.97)                                                               20.8 (1.4)                                                               17.8 (1.7)                                                               22.6 (2.0)   
    Yes                              56 (11.5)     4.27 (1.82)   0.86                                                        22.6 (1.4)   0.08                                                        21.7 (1.7)   0.007                                                       29.0 (2.0)   0.01
   Kidney disease                                                                                                                                                                                                                                                                           
    No                               455 (94.6)    4.36 (1.97)                                                               21.0 (1.4)                                                               18.4 (1.7)                                                               23.5 (2.0)   
    Yes                              26 (5.4)      4.33 (1.80)   0.96                                                        20.5 (1.2)   0.70                                                        15.7 (1.3)   0.12                                                        19.4 (1.7)   0.18
   Tuberculosis                                                                                                                                                                                                                                                                             
    No                               453 (94.4)    4.26 (1.95)                                                               20.9 (1.4)                                                               17.9 (1.7)                                                               23.0 (2.0)   
    Yes                              27 (5.6)      6.15 (1.94)   0.006                                                       23.4 (1.4)   0.08                                                        24.1 (1.7)   0.003                                                       28.6 (2.0)   0.11
   Dyslipidemia                                                                                                                                                                                                                                                                             
    No                               448 (92.8)    4.34 (1.96)                                                               21.0 (1.4)                                                               18.2 (1.7)                                                               23.2 (2.0)   
    Yes                              35 (7.2)      4.35 (1.82)   0.99                                                        21.0 (1.3)   0.95                                                        19.3 (1.7)   0.53                                                        24.3 (1.9)   0.72
   Hepatitis B                                                                                                                                                                                                                                                                              
    No                               439 (92.0)    4.38 (1.93)                                                               20.8 (1.4)                                                               18.0 (1.7)                                                               23.2 (2.0)   
    Yes                              38 (8.0)      4.44 (2.07)   0.91                                                        23.1 (1.4)   0.06                                                        21.6 (1.6)   0.03                                                        22.7 (1.8)   0.85

Values are presented as geometric mean (geometric standard deviation).

Hg, mercury; AST, aspartate aminotransferase; ALT, alanine transaminase; GGT, gamma-glutamyltransferase; KRW, Korean won.

*p*-values were calculated using the *t*-test or analysis of variance with natural log-transformed values of Hg, AST, ALT, and GGT.

###### 

Distribution of levels of blood Hg and liver enzymes at baseline and follow-up

  Survey wave (periods)   Blood Hg or liver enzymes   Mean (SD)     gMean (gSD)   Min    1st Q   Median   3rd Q   Max       *p*-value^[1](#tfn2-jpmph-50-6-377){ref-type="table-fn"}^
  ----------------------- --------------------------- ------------- ------------- ------ ------- -------- ------- --------- -----------------------------------------------------------
  Baseline (2010-2011)    Hg (μg/L)                   5.44 (4.40)   4.33 (1.94)   0.46   2.90    4.22     6.54    41.95     
  AST (IU/L)              22.8 (12.9)                 21.2 (1.4)    10.0          17.0   20.0    24.0     187.0             
  ALT (IU/L)              21.3 (15.2)                 18.3 (1.7)    5.0           13.0   17.0    24.0     153.0             
  GGT (IU/L)              31.9 (37.8)                 23.4 (2.0)    7.0           14.0   20.0    36.0     473.0             
  Follow-up (2014-2015)   Hg (μg/L)                   4.08 (3.44)   3.18 (2.00)   0.31   2.02    3.05     5.01    26.90     \<0.001
  AST (IU/L)              21.8 (16.2)                 18.3 (1.7)    2.5           13.0   17.0    25.0     169.0   \<0.001   
  ALT (IU/L)              22.5 (10.8)                 20.9 (1.4)    9.0           16.0   20.0    25.0     93.0    \<0.001   
  GGT (IU/L)              32.7 (42.2)                 23.8 (2.0)    6.0           14.0   21.0    36.0     589.0   0.38      

Hg, mercury; SD, standard deviation; gMean, geometric mean; gSD, geometric standard deviation; Min, minimum; 1st Q, 1st quartile; 3rd Q, 3rd quartile; Max, maximum; AST, aspartate aminotransferase; ALT, alanine transaminase; GGT, gamma-glutamyltransferase.

*p*-values were calculated using the paired *t*-test for differences in the geometric mean between survey waves.

###### 

Generalized linear model^[1](#tfn3-jpmph-50-6-377){ref-type="table-fn"}^ of associations between blood Hg levels and liver enzymes at baseline (2010-2011) and follow-up (2014-2015) by gender

           Survey wave   AST                ALT    GGT                                                                                            
  -------- ------------- ------------------ ------ ------------------ ------- ------------------------------------------------------------------- ------
  All      Baseline      -1.2 (-4.7, 2.5)          2.2 (-3.3, 7.9)            8.3 (1.8, 15.2)^[\*](#tfn6-jpmph-50-6-377){ref-type="table-fn"}^    
           Follow-up     3.6 (-2.2, 9.8)    0.03   -0.6 (-4.2, 3.1)   0.003   10.3 (3.5, 17.6)^[\*](#tfn6-jpmph-50-6-377){ref-type="table-fn"}^   0.60
  Men      Baseline      -2.5 (-7.9, 3.3)          0.7 (-7.3, 9.3)            6.1 (-4.8, 18.2)                                                    
           Follow-up     0.9 (-7.0, 9.4)    0.69   -3.1 (-8.6, 2.8)   0.16    9.4 (-2.0, 22.2)                                                    0.70
  Womene   Baseline      -0.5 (-5.3, 4.6)          3.0 (-4.4, 11.0)           9.7 (1.7, 18.2)^[\*](#tfn6-jpmph-50-6-377){ref-type="table-fn"}^    
           Follow-up     5.6 (-2.8, 14.7)   0.12   2.1 (-2.9, 7.3)    0.54    12.3 (3.5, 21.8)^[\*](#tfn6-jpmph-50-6-377){ref-type="table-fn"}^   0.61

Hg, mercury; AST, aspartate aminotransferase; ALT, alanine transaminase; GGT, gamma-glutamyltransferase.

Generalized linear model adjusted for gender (in all), age, income, fish consumption, smoking, frequency of alcohol consumption, and past medical history of hypertension, diabetes mellitus, tuberculosis, or hepatitis B measured at each period.

\% change of liver enzyme per doubling of blood Hg levels.

Interactions between blood Hg levels and survey wave in association with liver function indices were evaluated by the interaction term in the generalized estimating equation model.

*p*\<0.05.

###### 

Generalized estimating equation model of associations between blood Hg levels and liver enzymes from baseline (2010-2011) to follow-up (2014-2015), stratified by gender

                                                                                                                                                                         AST                                                                  ALT    GGT                                                                                                                                              
  -------------------------------------------------------------------------------------- ------------------------------------------------------------------------------- -------------------------------------------------------------------- ------ ------------------------------------------------------------------- ------ --------------------------------------------------------------------- -------
  Men                                                                                    Crude                                                                           1.8 (-2.4, 6.1)                                                             0.6 (-3.8, 5.3)                                                            12.7 (3.2, 23.0)^[\*](#tfn12-jpmph-50-6-377){ref-type="table-fn"}^    
                                                                                         Model 1                                                                         1.6 (-2.7, 6.0)                                                             -0.1 (-4.9, 4.8)                                                           10.4 (-0.1, 22.1)^[†](#tfn11-jpmph-50-6-377){ref-type="table-fn"}^    
                                                                                         Model 2                                                                         1.3 (-3.3, 6.0)                                                             -0.8 (-5.5, 4.1)                                                           7.5 (-1.8, 17.7)                                                      
                                                                                         Model 3                                                                         -0.1 (-4.7, 4.7)                                                            -1.2 (-5.6, 3.4)                                                           8.1 (-0.5, 17.4)^[†](#tfn11-jpmph-50-6-377){ref-type="table-fn"}^     
                                                                                         Alcohol consumption frequency^[3](#tfn9-jpmph-50-6-377){ref-type="table-fn"}^                                                                                                                                                                                                                                
                                                                                          ≤2-4 times/mo                                                                  3.6 (-2.3, 9.8)                                                             2.9 (-2.5, 8.6)                                                            7.6 (-2.0, 18.2)                                                      
                                                                                          ≥2-3 times/wk                                                                  -1.7 (-9.0, 6.2)                                                     0.88   -2.7 (-10.5, 5.7)                                                   0.31   13.5 (-2.0, 31.4)^[†](#tfn11-jpmph-50-6-377){ref-type="table-fn"}^    0.39
  Women                                                                                  Crude                                                                           6.9 (2.8, 11.2)^[\*](#tfn12-jpmph-50-6-377){ref-type="table-fn"}^           0.9 (-2.9, 4.8)                                                            7.0 (1.1, 13.3)^[\*](#tfn12-jpmph-50-6-377){ref-type="table-fn"}^     
                                                                                         Model 1                                                                         2.1 (-1.9, 6.2)                                                             1.8 (-2.2, 6.0)                                                            8.1 (1.4, 15.2)^[\*](#tfn12-jpmph-50-6-377){ref-type="table-fn"}^     
                                                                                         Model 2                                                                         2.2 (-1.7, 6.2)                                                             1.5 (-2.4, 5.6)                                                            9.1 (2.3, 16.3)^[\*](#tfn12-jpmph-50-6-377){ref-type="table-fn"}^     
                                                                                         Model 3                                                                         3.2 (-1.1, 7.6)                                                             2.4 (-1.7, 6.6)                                                            11.0 (4.5, 18.0)^[\*](#tfn12-jpmph-50-6-377){ref-type="table-fn"}^    
                                                                                         Alcohol consumption frequency^[3](#tfn9-jpmph-50-6-377){ref-type="table-fn"}^                                                                                                                                                                                                                                
                                                                                          ≤2-4 times/mo                                                                  2.5 (-2.2, 7.4)                                                             2.0 (-2.4, 6.7)                                                            7.8 (1.2, 14.7)^[\*](#tfn12-jpmph-50-6-377){ref-type="table-fn"}^     
                                                                                          ≥2-3 times/wk                                                                  10.6 (4.2, 17.5)^[\*](#tfn12-jpmph-50-6-377){ref-type="table-fn"}^   0.22   7.7 (1.1, 14.7)^[\*](#tfn12-jpmph-50-6-377){ref-type="table-fn"}^   0.37   37.5 (15.2, 64.3)^[\*](#tfn12-jpmph-50-6-377){ref-type="table-fn"}^   0.008
  *p* for interaction between genders^[4](#tfn10-jpmph-50-6-377){ref-type="table-fn"}^                                                                                   0.02                                                                        0.53                                                                       0.82                                                                  

Model 1 included age, income, and study period in the crude model; Model 2 included fish consumption, smoking, and frequency of alcohol consumption in addition to model 1; Model 3 included past medical history of hypertension, diabetes mellitus, tuberculosis, or hepatitis B in addition to model 2. In each model, age, income, period, fish consumption, smoking, and frequency of alcohol consumption, as well as blood Hg and liver enzyme levels, were considered to be time-varying covariates.

Hg, mercury; CI, confidence interval; AST, aspartate aminotransferase; ALT, alanine transaminase; GGT, gamma-glutamyltransferase.

\% change of liver enzyme per doubling of blood Hg level.

The multiplicative interaction between blood Hg levels and frequency of alcohol consumption in association with liver enzymes was evaluated by the interaction term in the corresponding model.

After stratification by frequency of alcohol consumption, the same covariates as model 3 were included.

The multiplicative interaction between blood Hg levels and gender in association with liver enzymes was evaluated by the interaction term in the corresponding model (model 3).

*p*\<0.1,

*p*\<0.05.
